A Multicenter Double-Blind, Randomized Controlled Study of Etanercept and Methotrexate in Combination or as Monotherapy in Subjects With Psoriatic Arthritis
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 02 Feb 2018
At a glance
- Drugs Etanercept (Primary) ; Methotrexate (Primary)
- Indications Psoriatic arthritis
- Focus Registrational; Therapeutic Use
- Sponsors Amgen
- 30 Nov 2017 Planned End Date changed from 30 Jul 2018 to 6 Jul 2018.
- 30 Nov 2017 Planned primary completion date changed from 15 Jan 2018 to 22 Dec 2017.
- 25 Jul 2017 Status changed from recruiting to active, no longer recruiting.